Oppenheimer raises UroGen Pharma stock price target to $50 on sales outlook

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A IBM cut at Oppenheimer as software bull thesis will take longer to materialize Hisse Senetleri 0 3
A Top Agriculture & Infrastructure Stock Pick From Oppenheimer Hisse Senetleri 0 7
A Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers Hisse Senetleri 0 6
A Oppenheimer downgrades Goldman Sachs stock rating on valuation concerns Hisse Senetleri 0 10
A Oppenheimer raises Neurocrine Biosciences price target on acquisition Hisse Senetleri 0 51
A Oppenheimer raises Ionis Pharmaceuticals price target on pricing move Hisse Senetleri 0 39
A Oppenheimer raises Nektar Therapeutics price target to $140 Hisse Senetleri 0 61
A Oppenheimer raises Biogen stock price target to $250 on long-term growth outlook Hisse Senetleri 0 52

Benzer konular

Üst